OTO OpenPub Date : 2026-10-06eCollection Date: 2026-10-01DOI: 10.1002/oto2.70314
Clara D Si, Whitney Jin, Brooke Swain, Jean-Nicolas Gallant, Robert J Sinard, Eben L Rosenthal, Sarah L Rohde, Kyle Mannion, Alexander J Langerman, Michael C Topf
{"title":"Survival and Recurrence Patterns After Total Laryngectomy in Young Laryngeal Squamous Cell Carcinoma Patients.","authors":"Clara D Si, Whitney Jin, Brooke Swain, Jean-Nicolas Gallant, Robert J Sinard, Eben L Rosenthal, Sarah L Rohde, Kyle Mannion, Alexander J Langerman, Michael C Topf","doi":"10.1002/oto2.70314","DOIUrl":"10.1002/oto2.70314","url":null,"abstract":"<p><strong>Objective: </strong>The prognostic role of age in laryngeal squamous cell carcinoma (LSCC) remains unclear, particularly regarding recurrence after total laryngectomy (TL). This study evaluated the impact of age on LSCC outcomes following TL.</p><p><strong>Study design: </strong>Retrospective single-institution cohort study.</p><p><strong>Setting: </strong>Academic tertiary medical center.</p><p><strong>Methods: </strong>We reviewed LSCC patients who underwent TL between 1999 and 2024 grouped by age at surgery: <45 versus ≥45 years. Overall survival (OS) and disease-free survival (DFS) were assessed using Kaplan-Meier and log-rank tests. Site-specific recurrence was analyzed using cumulative incidence functions with Gray's test. Multivariable competing risk regressions with the Fine-Gray model evaluated the association of age with recurrence.</p><p><strong>Results: </strong>Among 646 TL patients, 17 were <45 years. Five-year OS was 82.0% for <45 versus 54.3% for ≥45 (<i>P</i> = .023); 5-year DFS was 70.2% versus 42.9% (<i>P</i> = .023). There was no significant difference in overall recurrence between age groups. Competing risk analysis showed no significant difference in cumulative incidence of local, regional, or distant recurrence. In multivariable analysis adjusting for T stage, N stage, laryngectomy indication, and adjuvant therapy, younger age was not independently associated with recurrence (sHR 0.55, 95% CI 0.18-1.63, <i>P</i> = .28).</p><p><strong>Conclusions: </strong>Younger LSCC TL patients demonstrated improved OS and DFS despite comparable recurrence risk. Age was not independently associated with recurrence, suggesting that improved survival in younger patients does not reflect differences in oncologic control. These findings highlight the importance of distinguishing survival from recurrence outcomes and underscore the need for larger studies evaluating survival differences in younger patients.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 4","pages":"e70314"},"PeriodicalIF":1.6,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13640527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149113042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-29eCollection Date: 2026-07-01DOI: 10.1002/oto2.70307
Yousef M Al-Shammari, Bisher Albesher, Sarah M Murad, Dhari Altaher, Nourah H AlGhurair, Ahmad S Alawadhi, Hasan Alshemari
{"title":"Steroid Injection in Patients With Benign Vocal Fold Lesions: A Meta-Analysis and Meta-Regression.","authors":"Yousef M Al-Shammari, Bisher Albesher, Sarah M Murad, Dhari Altaher, Nourah H AlGhurair, Ahmad S Alawadhi, Hasan Alshemari","doi":"10.1002/oto2.70307","DOIUrl":"10.1002/oto2.70307","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to assess the efficacy and safety of steroid injections in patients with benign vocal fold lesions.</p><p><strong>Data sources: </strong>PubMed, Scopus, and Embase were searched from January 2000 through December 2025 using predefined terms for benign vocal fold pathology and steroid injection.</p><p><strong>Review methods: </strong>We conducted a PRISMA-guided systematic review and meta-analysis of studies evaluating steroid injections for benign vocal fold lesions. Study selection and data extraction were performed independently by two reviewers. Study quality was assessed using NIH (cohort studies), JBI (case series), and RoB 2 (RCTs). Random-effects meta-analysis (DerSimonian-Laird) was performed in OpenMeta[Analyst], with Freeman-Tukey double arcsine transformation for proportional outcomes.</p><p><strong>Results: </strong>Fourteen studies were included. Posttreatment VHI pooled mean was 17.585 (95% CI 10.61-24.55; <i>I</i> <sup>2</sup> = 97%), while VHI change was not statistically significant (-6.948; 95% CI -16.06 to 2.16; <i>I</i> <sup>2</sup> = 98%), indicating substantial between-study heterogeneity and limited certainty in pooled VHI effect estimates. MPT improved, with post-treatment pooled mean 13.24 seconds (95% CI 12.54-13.94; <i>I</i> <sup>2</sup> = 73%) and pooled change 1.81 seconds (95% CI 1.10-2.52; <i>I</i> <sup>2</sup> = 71%). Complications were uncommon (1.5%; <i>I</i> <sup>2</sup> = 0%). Overall improvement was 92%, recurrence 15.2%, complete remission 42.5%, partial remission 39.6%, and no response 9.4%.</p><p><strong>Conclusion: </strong>Steroid injection was associated with high clinical improvement and low complication rates. However, VHI demonstrated substantial heterogeneity and inconsistent statistical significance across studies, limiting the robustness and generalizability of pooled quality-of-life estimates. These findings support steroid injection as a minimally invasive option in selected patients but highlight the need for standardized protocols and higher-quality comparative trials to better define its effect on patient-reported voice outcomes.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70307"},"PeriodicalIF":1.6,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13621230/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149081187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-28eCollection Date: 2026-07-01DOI: 10.1002/oto2.70309
Guilherme R Agne, Valdenor N Feitosa, Antonio Bertelli, Rafael de Cicco, Luiza H C da Silva, Leandro L Matos, Bruno M Murara, Renan B Lira, Everson L de Almeida Artifon, Luiz P Kowalski
{"title":"Preclinical Simulation of Transoral Robotic Thyroidectomy Using a Training Box and the Versius Robotic Platform.","authors":"Guilherme R Agne, Valdenor N Feitosa, Antonio Bertelli, Rafael de Cicco, Luiza H C da Silva, Leandro L Matos, Bruno M Murara, Renan B Lira, Everson L de Almeida Artifon, Luiz P Kowalski","doi":"10.1002/oto2.70309","DOIUrl":"10.1002/oto2.70309","url":null,"abstract":"<p><p>Transoral robotic thyroidectomy (TORT) represents an alternative to open surgery, offering favorable cosmetic outcomes and comparable oncologic results. However, standardized training pathways and validated simulation models replicating standardized setups for emerging robotic platforms remain limited. An experimental simulation of total thyroidectomy and central (recurrent) neck dissection was performed with the Versius robotic system in a validated synthetic training box. Optimal robotic positioning and docking were determined, and a standardized procedural sequence was followed to ensure optimal results. Simulation was successful only with a C-shaped configuration of the robotic arms and a posteriorly positioned camera in a Z-shaped layout, matching prior cadaveric findings. All thyroidectomy steps proceeded smoothly. However, during central neck dissection, instrument collisions limited access to deeper spaces, restricting maneuverability. The training box allowed successful simulation of TORT with the Versius system in this proof-of-concept study, providing a platform for evaluating robotic positioning and docking configurations and supporting further investigation of its potential applications in training and preclinical assessment.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70309"},"PeriodicalIF":1.6,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13618370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149075575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-25eCollection Date: 2026-07-01DOI: 10.1002/oto2.70284
Mayuri Yasuda, Aayushma Regmi, Maitri Mehta, Cullen M Lilley, Eric Thorpe, Swati Mehrotra, Andrea Ziegler, Vijayalakshmi Ananthanarayanan
{"title":"Histopathological Patterns of Metastatic Cutaneous Squamous Cell Carcinoma to Intra-Parotid Lymph Nodes and Correlation With Outcomes.","authors":"Mayuri Yasuda, Aayushma Regmi, Maitri Mehta, Cullen M Lilley, Eric Thorpe, Swati Mehrotra, Andrea Ziegler, Vijayalakshmi Ananthanarayanan","doi":"10.1002/oto2.70284","DOIUrl":"10.1002/oto2.70284","url":null,"abstract":"<p><strong>Objective: </strong>Metastatic cutaneous squamous cell carcinoma (cSCC) to the parotid gland is an uncommon but serious disease process. This study evaluates the histopathological patterns of cSCC metastases to the parotid and correlates with recurrence rates and other clinical outcomes.</p><p><strong>Study design: </strong>This was a retrospective cohort study.</p><p><strong>Setting: </strong>The study was conducted at a single tertiary care center.</p><p><strong>Methods: </strong>Cases of cSCC with metastasis to the parotid between 2016 and 2022 were included. The histological slides from the parotidectomy were reviewed to determine the WPOI. The patient's history, operative and surgical pathology reports, and postoperative clinic notes were also reviewed.</p><p><strong>Results: </strong>There was a total of 46 primary tumors. Most cases were located on the pinna, followed by temple and scalp. Patients with WPOI 4/5 were more likely to have received prior adjuvant treatment after initial excision of their primary (<i>P</i> = .035).These tumors were clinically aggressive. 54.3% had perineural invasion (PNI). Histologically, 71.1% were infiltrative with a median WPOI of 3. PNI was the only statistically significant histological factor associated with a higher risk of postparotidectomy recurrence (<i>P</i> = .036). Univariate logistic regression showed that patients with PNI were more likely to have recurrence (OR 8.33, <i>P</i> = .023).</p><p><strong>Conclusion: </strong>There were no statistically significant differences in outcomes when comparing WPOI groups. However, PNI, even at a metastatic site, was noted to be a significant risk factor for recurrence in these tumors, supporting prior evidence that PNI is an important factor to consider when determining treatment options in these clinically aggressive malignancies.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70284"},"PeriodicalIF":1.6,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13615334/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149063122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Computed Tomography-Measured Minimum Fascia-Tumor Distance for Parotid Tumor Location and Facial Palsy Prediction.","authors":"Yi-Chan Lee, Li-Yu Lee, Chi-Yin Lee, Ti-Yung Tseng, Yao-Te Tsai, Chih-Chen Chang, Kai-Ping Chang","doi":"10.1002/oto2.70302","DOIUrl":"10.1002/oto2.70302","url":null,"abstract":"<p><strong>Objective: </strong>To assess the diagnostic performance of CT-measured minimum fascia-tumor distance (MFTD) for predicting parotid tumor location and its association with postoperative facial nerve function.</p><p><strong>Study design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Referral hospital.</p><p><strong>Methods: </strong>This retrospective cohort study included 323 patients with benign parotid tumors treated at referral centers. CT-measured MFTD values were compared between superficial and deep lobe tumors. Diagnostic accuracy for identifying deep lobe tumors was evaluated using a receiver operating characteristic (ROC) curve. Univariable and multivariable logistic regression analyses were performed to identify predictive factors for tumor location and postoperative facial palsy.</p><p><strong>Results: </strong>MFTD significantly differed between superficial and deep lobe tumors (1.59 ± 2.14 mm vs. 3.90 ± 3.40 mm, <i>p</i> < .001). ROC analysis yielded an area under the curve of 0.70 (95% confidence interval [CI], 0.60-0.79; <i>p</i> < .001), with 3.0 mm identified as the optimal threshold. Independent predictors of deep lobe tumors included MFTD (odds ratio [OR], 1.34; 95% CI, 1.19-1.49; <i>p</i> < .001) and maximal tumor diameter (OR, 1.03; 95% CI, 1.00-1.06; <i>p</i> = .043). Predictors of postoperative temporary facial palsy were MFTD (OR, 1.26; 95% CI, 1.11-1.42; <i>p</i> < .001), female sex (OR, 3.17; 95% CI, 1.49-6.73; <i>p</i> = .003), and anterior tumor location (OR, 2.69; 95% CI, 1.21-6.00; <i>p</i> = .016).</p><p><strong>Conclusion: </strong>CT-based MFTD provides reliable diagnostic performance for distinguishing deep lobe parotid tumors. Beyond tumor localization, MFTD also predicts the risk of postoperative temporary facial palsy. Incorporating MFTD into preoperative planning and patient counseling may enhance surgical decision-making and outcomes.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70302"},"PeriodicalIF":1.6,"publicationDate":"2026-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13602983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149040282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-16eCollection Date: 2026-07-01DOI: 10.1002/oto2.70305
Audrey Abend, Sophia Salingaros, Adrienne Biskaduros, Matthew Spano, Matthew Wright, Sara Strauss, Jason A Spector, David I Kutler
{"title":"Investigating Neotongue Atrophy and Postoperative Outcomes in Patients Undergoing Glossectomy With Free Flap Tongue Reconstruction.","authors":"Audrey Abend, Sophia Salingaros, Adrienne Biskaduros, Matthew Spano, Matthew Wright, Sara Strauss, Jason A Spector, David I Kutler","doi":"10.1002/oto2.70305","DOIUrl":"https://doi.org/10.1002/oto2.70305","url":null,"abstract":"<p><strong>Objective: </strong>Following glossectomy, tongue reconstruction via autologous free flap can reapproximate native form and function, significantly improving postoperative quality of life. Various studies have examined functional outcomes between the commonly employed radial forearm free flap (RFFF) and the anterolateral thigh free flap (ALTFF); however, changes in neotongue volumetric bulk are less clearly understood.</p><p><strong>Study design: </strong>We aimed to assess postoperative outcomes and volume changes in patients undergoing glossectomy.</p><p><strong>Setting: </strong>This is a retrospective chart review of patients who underwent glossectomy with reconstruction at a single academic center.</p><p><strong>Methods: </strong>Patients who underwent hemiglossectomy with RFFF or ALTFF reconstruction were retrospectively identified. Patient demographics, past medical history, and treatment course were collected. Perioperative imaging was utilized to measure native tongue, tumor, and postoperative neotongue volumes.</p><p><strong>Results: </strong>Of 35 patients identified, ALTFF patients presented with greater tumor stage and depth of invasion than RFFF patients. Volumetric analysis of 17 patients revealed a mean tongue size decrease of 31.68 cm<sup>3</sup> (SD, 42.02). Correlational analyses revealed a significant negative relationship of tongue volume over time (Spearman coefficient = -0.52, <i>P</i> = .04). Length of time was significant independent of flap type or mass volume (<i>F</i> = 4.85, <i>P</i> = .046). No significant relationship was found between flap type, tumor size, and change in total tongue size. ALTFF patients trended towards a greater rate of percutaneous endoscopic gastrostomy (PEG) tube dependence than RFFF patients at 1 month, but by 3 months all patients tolerated oral intake; however, ALTFF patients demonstrated a smaller absolute reduction in body mass index (BMI) compared to RFFF patients.</p><p><strong>Conclusion: </strong>Postoperative neotongue volume decreased in both the ALTFF and RFFF cohorts over time but was not impacted by flap type or tumor burden. Further research is warranted to understand the impact of flap design on neotongue atrophy.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70305"},"PeriodicalIF":1.6,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13581267/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148990941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-14eCollection Date: 2026-07-01DOI: 10.1002/oto2.70298
David Fei-Zhang, Meredith Osmulski, Christopher Puchi, Abhinav Talwar, Jorge Gutierrez, John Maddalozzo, Jill D'Souza, Anthony Sheyn, Daniel Chelius, Jeffrey Rastatter
{"title":"Racial-Ethnic Differences of Community Vulnerability Impact on Pediatric Thyroid Cancer Diagnosis and Surveillance.","authors":"David Fei-Zhang, Meredith Osmulski, Christopher Puchi, Abhinav Talwar, Jorge Gutierrez, John Maddalozzo, Jill D'Souza, Anthony Sheyn, Daniel Chelius, Jeffrey Rastatter","doi":"10.1002/oto2.70298","DOIUrl":"10.1002/oto2.70298","url":null,"abstract":"<p><strong>Objective: </strong>To assess racial-ethnic differences of community-level social vulnerability impact on pediatric thyroid cancer diagnosis and surveillance.</p><p><strong>Study design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>United States.</p><p><strong>Methods: </strong>This retrospective analysis of 4324 pediatric thyroid cancer patients diagnosed between 1975 and 2017 from the Surveillance-Epidemiology-End Results (SEER) data set assessed overall social vulnerability aggregated from 15 different social vulnerabilities of health of socioeconomic status, minority-language status, household composition, and housing-transportation from the social vulnerability index (SVI). Social vulnerability scores of each category were matched to patients across US counties. Across racial-ethnic strata (non-Hispanic-white/non-white), age-adjusted regression analyses assessed surveillance period, lymph node metastasis, and number of primary tumors with increasing social vulnerability scores.</p><p><strong>Results: </strong>For non-Hispanic-white (n = 2666) and non-white (n = 1658) pediatric thyroid cancer patients, surveillance times at the lowest and highest-total SVI levels were higher among white (162.92 and 108.02 months, respectively) compared to non-white patients (117.64; 96.96). For lymph node metastasis, increasing SVI was associated with increased occurrence among non-white pediatric thyroid cancer patients (odds ratio [OR] 1.16, 95% CI 1.05-1.27) but not among white patients (0.96, 0.89-1.03). For multiple primary tumors on presentation, no significant differences were observed across both race-ethnic groups.</p><p><strong>Conclusion: </strong>Increasing community-level social vulnerability correlated with worse pediatric thyroid cancer surveillance, especially for non-white pediatric thyroid cancer patients in diagnostic and care outcomes. Through assessing upstream and downstream effects of social vulnerability on pediatric thyroid cancer patients, this multilevel approach allows nuanced considerations of one's individual racial-ethnic identity and their community to elucidate how non-clinical factors have disproportionate effects on the diagnosis of pediatric thyroid cancers.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70298"},"PeriodicalIF":1.6,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13574208/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148970443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-13eCollection Date: 2026-07-01DOI: 10.1002/oto2.70304
Michael F Armstrong, Kathleen R Bartemes, Danielle E Hunter, Marisa D Griesel, Stephen G Voss, Garret W Choby, Carlos D Pinheiro Neto, John B Hagan, Rohit D Divekar, Erin K O'Brien
{"title":"Comparison of Nasal Mucus Metabolites in Chronic Rhinosinusitis With and Without Polyps and Healthy Controls.","authors":"Michael F Armstrong, Kathleen R Bartemes, Danielle E Hunter, Marisa D Griesel, Stephen G Voss, Garret W Choby, Carlos D Pinheiro Neto, John B Hagan, Rohit D Divekar, Erin K O'Brien","doi":"10.1002/oto2.70304","DOIUrl":"10.1002/oto2.70304","url":null,"abstract":"<p><strong>Objective: </strong>To identify differences in nasal mucus metabolites from patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP) and healthy controls.</p><p><strong>Study design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>Single institution tertiary care facility.</p><p><strong>Methods: </strong>Patients were assigned to groups based on the appearance of normal mucosa (control [n = 5]), diseased mucosa ([CRSsNP] [n = 6]), or polypoid mucosa ([CRSwNP] [n = 4]), respectively. Mucus was collected on swabs. Nasal mucus metabolites were quantified via untargeted metabolomics using liquid chromatography-mass spectrometry (LC-MS) for detection of all metabolites observable with the method. Metabolites in biochemical pathways implicated in sinonasal disease were further selected for analysis.</p><p><strong>Results: </strong>In the glycerophospholipid pathway, glycerophosphocholine and glycerol-3-phosphate were significantly elevated in controls (C) compared to the CRSwNP and CRSsNP groups (false discovery rate [FDR] = 0.03, C vs CRSwNP fold change [FC] = 3.83, C vs CRSsNP FC = 3.92 and FDR = 0.02, C vs CRSwNP FC = 3.05, C vs CRSsNP FC = 3.50, respectively). In the sphingolipid pathway, C24-OH sulfatide and dihydroceramide were significantly elevated in CRSwNP compared to CRSsNP and control mucus (FDR = 0.01, CRSwNP vs C FC = 146.75, CRSsNP vs C FC = 45.55, CRSwNP vs CRSsNP FC = 3.22 and FDR = 0.05, CRSwNP vs C FC = 4.40, CRSwNP vs CRSsNP FC = 2.72, respectively).</p><p><strong>Conclusion: </strong>Glycerophosphocholine and sphingolipid nasal mucus metabolites differed between patients with subtypes of CRS and controls. Nasal mucus metabolites may aid in differentiating subtypes of sinusitis.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70304"},"PeriodicalIF":1.6,"publicationDate":"2026-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13571607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148963666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
OTO OpenPub Date : 2026-09-11eCollection Date: 2026-07-01DOI: 10.1002/oto2.70301
Emily S Sagalow, Caroline Liu, Samir Alkhouri, Harry H Ching
{"title":"Exploring Complications of Orbital Floor Reconstructive Implants Using the MAUDE Database.","authors":"Emily S Sagalow, Caroline Liu, Samir Alkhouri, Harry H Ching","doi":"10.1002/oto2.70301","DOIUrl":"10.1002/oto2.70301","url":null,"abstract":"<p><strong>Objective: </strong>Orbital floor fractures are commonly treated with alloplastic implants, yet comparative safety data on implant materials remain limited. This study evaluates the adverse event (AE) profiles of commonly used orbital floor implants using a national device surveillance database.</p><p><strong>Study design: </strong>Retrospective database analysis.</p><p><strong>Setting: </strong>Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database.</p><p><strong>Methods: </strong>The MAUDE database was queried for AEs related to 13 orbital floor reconstructive implants from 7 manufacturers. Reported events were categorized by implant type and classified as malfunction, injury, or other.</p><p><strong>Results: </strong>A total of 90 AEs were identified across 4 implant types. Porous polyethylene SynPor® accounted for 69 events (76.7%), followed by porous polyethylene MEDPOR TITAN® with 15 (18.1%), porous polyethylene Su-Por® with 4 (4.8%), and smooth nylon foil SupraFOIL® with 2 (2.4%). Most AEs were categorized as malfunctions (n = 64, 77.1%), while 19 (21.1%) were reported as injuries. No malfunctions resulted in patient harm. All reported cases of implant infection or extrusion occurred with polyethylene implants. Overall, 97.6% of AEs involved polyethylene-based devices. No AEs were reported for titanium, poly-l/ dl-lactide, polycaprolactone, or PDS implants.</p><p><strong>Conclusion: </strong>Within the MAUDE database, AEs were most frequently reported for porous polyethylene implants. These findings represent the first systematic characterization of MAUDE-reported AEs for orbital floor implants and identify porous polyethylene as the predominant implant type captured in national postmarket surveillance. Prospective comparative studies are needed to evaluate material-specific complication rates and further guide implant selection.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70301"},"PeriodicalIF":1.6,"publicationDate":"2026-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13568600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Anatomical Feature of Nasal Cavity for Endoscopic Endonasal Skull Base Surgery in Patients With GHoma.","authors":"Tomoharu Suzuki, Noritaka Komune, Yusuke Miyamoto, Daisuke Kuga, Yuhei Sangatsuda, Ryota Higuchi, Yuichi Saito, Daisuke Murakami, Koji Yoshimoto, Takashi Nakagawa","doi":"10.1002/oto2.70297","DOIUrl":"10.1002/oto2.70297","url":null,"abstract":"<p><strong>Background: </strong>Endoscopic endonasal skull base surgery (EESS) is widely performed for pituitary tumors. In growth hormone-secreting adenomas (GHomas), the procedure is technically more demanding than for other pituitary neuroendocrine tumor (PitNET) subtypes due to restricted instrument maneuverability. Few studies have evaluated the influence of nasal cavity morphology on this difficulty.</p><p><strong>Objective: </strong>To identify anatomical factors contributing to the technical challenges of EESS for GHomas by comparing nasal cavity structures between GHoma and non-GHoma PitNET patients.</p><p><strong>Study design: </strong>Retrospective chart review.</p><p><strong>Setting: </strong>Tertiary referral center with a collaborative skull base team of neurosurgery and otolaryngology.</p><p><strong>Methods: </strong>Computed tomography (CT) images of 28 GHoma and 104 non-GHoma PitNET patients who underwent EESS between August 2018 and April 2024 were analyzed. Measurements included inter-vidian canal distance, nasolacrimal duct opening width, inferior turbinate width, piriform aperture width, sphenopalatine foramen width, inter-carotid artery distance, skull base-to-hard palate distance, anterior nasal spine-to-clivus distance, and anterior sphenoid wall-to-clivus distance. Comparisons were performed using Student's <i>t</i>-test.</p><p><strong>Results: </strong>GHoma patients showed significantly greater nasolacrimal duct opening width, piriform aperture width, and anterior nasal spine-to-clivus distance (<i>P</i> < .05). Vertical-to-horizontal ratios did not differ significantly. However, the inter-carotid artery distance and the ratios of inter-carotid distances to the anterior nasal spine-to-clivus distance were significantly smaller in GHomas.</p><p><strong>Conclusion: </strong>GHoma patients possess generally larger sinonasal dimensions, yet a narrower paraclival inter-carotid space limit surgical maneuverability. These CT-based anatomical differences may have potential implications for preoperative anatomical assessment in patients with GHomas.</p><p><strong>Level of evidence: </strong>IV.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"10 3","pages":"e70297"},"PeriodicalIF":1.6,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13555794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148920208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}